This is the authors' abstract. We don't add key points for this paper.
A virus immunoprecipitin radioassay (VIR) was developed to quantitate influenza virus interaction with specific antibody. After the initial virus-antibody reaction, quantitative binding of isotopically labeled anti-IgG resulted in the final formation of a virus immunoprecipitate. The anti-IgG radioactivity incorporated in this virus immunoprecipitate was a measure of the variation in any one of the reactants. This finding confirmed that the immunologic specificity of the VIR procedure was directly dependent upon virus antigen concentration and virus antibody dilution for proportional binding of the 125I-labeled anti-IgG with no prozone activity. Competitive inhibition of labeled anti-IgG antibody by unlabeled anti-IgG for detecting specifically bound virus antibody indicates the sensitivity of the virus immunoprecipitin reaction. Alternate methods for eliminating unbound anti-IgG from the virus immunoprecipitin complex, the carrier precipitate and the sucrose gradient methods were used. In the sucrose gradient method, the changes in the reactants, as evidenced by sedimentation behavior, were quantitative and proportional to the dilution of influenza antibody. Hemagglutination inhibition is no more reproducible and is not as sensitive or precise as the VIR for quantitating influenza-specific antibody. Correlation between the two tests indicates that they probably measure the same factor of influenza-specific antibody.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Harry Daugharty (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: